Today, EuropaBio announces Dr Claire Skentelbery as its new Director General as of November 23rd.
“I am delighted to welcome Claire into the EuropaBio team. She comes with great expertise, both in the biotech sector as well as in leading a trade association. In her most recent position as the Director General of the NIA, Claire has shown great success increasing the visibility and impact of the association. Claire joins us at an exciting time for biotech in Europe and this is why I am so pleased she has agreed to lead the excellent EuropaBio team for the next chapter in our journey“, EuropaBio Chairman Andrew Topen stated.
Commenting on her appointment, Claire added that “I am proud to join an association so pivotal in the positioning, success and global representation of European biotechnology. Biotechnology is central to a healthy and sustainable Europe and we are at a key point in time to deliver innovation, policy and economic ambitions. I look forward to working with the global biotech community with such a talented and motivated team.”
Claire holds a PhD in biochemistry and has worked in the development of scientific networks and associations for over 15 years. She started her career as part of the Cambridge biotech cluster in the UK within the cluster business network and was a founder of the Council of European BioRegions, a network of biotech clusters across Europe. She brought herself and CEBR to Brussels in 2009 where she also took on the role of SG for the European Biotechnology Network, working across sectors, organisations and countries as part of the EBN mission to facilitate partnerships. In January 2017, Claire took up her role as DG of the Nanotechnology Industries Association which she successfully led until recently.